Apr 11

Navigating a World Without Antibiotics

The Post-Antibiotic Apocalypse

For nearly a century, we have enjoyed a golden age of medicine where the risk of death from a simple scratch or an annoying cough has largely vanished. Antibiotics are a cornerstone of modern healthcare, yet their effectiveness is often taken for granted, and they are frequently used for even minor ailments. However, this sense of security is quickly eroding as bacteria develop resistance to these drugs, leading us towards a "post-antibiotic era" in which common infections could once again be deadly.

Life Before Penicillin

To grasp what we stand to lose, we need to examine the medical landscape before the discovery of penicillin in 1928. During that period, infectious diseases caused high levels of serious illness and death, and the average life expectancy was often less than 50 years, even in countries with advanced healthcare.

  • Fatal Minorities: Conditions we now regard as minor, like ear or throat infections, were once potentially fatal; an ear infection could readily spread to the brain.
  • Death Sentences: Bacterial meningitis had a 90% mortality rate among children, and those who survived often faced lifelong disabilities.
  • The Pneumonia Threat: Before antibiotics, one in three patients diagnosed with pneumonia died.
  • Drastic measures: Simple cuts and scrapes often developed into serious systemic infections, frequently necessitating the amputation of a limb.
  • Dangerous Deliveries: Childbirth was a high-risk event for both mother and child due to the lack of medicine to fight infection during pregnancy and post delivery.

The Problems Caused by Antibiotic Loss

Losing effective antibiotics would not only revert us to the 1920s; it would also hinder progress in modern medicine. Advances in healthcare rely on controlling infections in society generally, during and after surgery, as well as on successful cancer treatments.

  • High-stakes surgery: routine procedures such as hip replacements, heart surgeries, and organ transplants could become impossible due to the high risk of untreatable post-operative sepsis.
  • The Chemotherapy Crisis: Cancer treatments, which suppress the immune system, depend on antibiotics to keep patients safe; without them, the risk of a deadly infection during chemotherapy would be too high to justify the treatment.
  • Neonatal Vulnerability: About 3 million newborns suffer from sepsis each year; currently, 30% of neonatal sepsis deaths are caused by antibiotic-resistant bacteria.
  • Pan-Resistant "Superbugs": We are already witnessing "pan-resistant" infections that do not respond to any known antibiotics, including cases of Klebsiella pneumoniae and Pseudomonas aeruginosa, which have caused rapid patient death from septic shock.
  • The Economic Toll: If not addressed, antibiotic resistance could lead to a 3.8% drop in global GDP by 2050, potentially forcing 24.1 million people into severe poverty.

The Role of Stewardship (AMS) in the Crisis

This "post-antibiotic apocalypse" is driven by failures in antimicrobial stewardship (AMS), which aims to use these drugs more responsibly and appropriately.

  • Human Misuse: Using antibiotics for viral infections (where they are ineffective) and patients failing to complete their prescribed courses, enables bacteria to adapt and develop resistance.
  • Agricultural Drivers: In the U.S., for example, approximately 80% of antibiotics are purchased for use in livestock management, primarily for growth promotion or routine disease prevention in often crowded and unsanitary conditions.
  • Selective Pressure: Each time an antibiotic is used - whether appropriately or not - it applies selective pressure, killing vulnerable bacteria while letting resistant strains survive and multiply.
  • Environmental Spillover: Resistant bacteria from farms and pharmaceutical manufacturing are released into soil and groundwater, eventually reaching human populations through the food chain or by direct contact.

What Remains in Our Arsenal?

While the antibiotics “pipeline” is described as "almost dry," we have several essential non-drug strategies and emerging technologies to fight infections.

  • WASH (Water, Sanitation, and Hygiene): Improving global access to clean water and sanitation could reduce diarrhoea cases treated with antibiotics by 60%. Hand hygiene remains a vital, cost-effective barrier against the spread of resistant pathogens.
  • Vaccination: Vaccines prevent infections before they occur, reducing the need for antibiotics; for instance, universal coverage of the pneumococcal vaccine could prevent 11.4 million days of antibiotic use in children annually.
  • Surveillance Systems: Initiatives like the Global Antimicrobial Resistance and Use Surveillance System (GLASS) assist in monitoring resistance trends and pinpointing hotspots, enabling targeted public health interventions.
  • Innovation Incentives: As developing new antibiotics is financially risky for pharmaceutical companies, governments are exploring "push" funding (grants for research) and "pull" funding (market rewards for successful drugs) to revitalise the antibiotic pipeline.
  • Target Product Profiles (TPPs): The WHO has identified global priorities for innovation, focusing on severe multidrug-resistant Gram-negative infections and bacterial meningitis.
  • Alternatives to Traditional Drugs: Research is broadening into fungal-based bioactive compounds and "drugs of last resort" such as colistin, although even these are facing increasing resistance.

A Shared Societal Trust

Antibiotics are special because they can lose their effectiveness with each transmission; your use of an antibiotic today might affect your neighbour’s ability to use it effectively tomorrow. We must view these medicines as a shared societal resource rather than a disposable commodity. Protecting their power requires a "One Health" approach, recognising that human, animal, and environmental health are fundamentally linked.

Conclusion

The threat of a world without antibiotics isn't a distant illusion but a slow-moving pandemic already underway. We've witnessed the devastating reality of the pre antibiotic era and now face a future where even our most advanced medical procedures could become deadly. However, by adopting strict antimicrobial stewardship, investing in vaccines and sanitation, and encouraging innovation, we can still safeguard this vital medical legacy. The decisions we make today - as patients, healthcare providers, and policymakers - will determine whether antibiotics remain a reliable safeguard for future generations.

See more of our blogs on the HUB – or ask a question of EVE. Still need help? Contact
our team at support@infection control.care

We are on Facebook and LinkedIn – be sure to like and share

Take advantage of our expertise in IPC. See the HUB for policies, resources and courses relating to this very important subject. Ask EVE for a quick answer to your question.